Bayer Healthcare LLC v. Norbrook Laboratories Ltd et al

Filing 249

SEVENTH AMENDED SCHEDULING ORDER signed by Judge Rudolph T Randa on 12/09/2011 granting 248 Motion to Amend/Correct. Expert Witness Lists due by 2/17/2012; Telephonic Final Pretrial Conference set for 3/26/2012 02:00 PM; Jury Trial set for 4/16/2012 09:00 AM in Courtroom 320, 517 E Wisconsin Ave., Milwaukee, WI 53202 before Judge Rudolph T Randa. (cc: all counsel) (Koll, J)

UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF WISCONSIN
BAYER HEALTHCARE, LLC,
Plaintiff,
Case No. 08-00953
vs.
NORBROOK LABORATORIES, LTD. and
NORBROOK, INC. USA,
Defendants.

SEVENTH AMENDED SCHEDULING ORDER

The Scheduling Order entered by this Court on March 29, 2011 in the above-titled action
is hereby amended and restated.
IT IS ORDERED that:
1.

This case will be tried to the Court. This case will be called for trial at 9:00 a.m.

(CT) on April 16, 2012 [previously: February 6, 2012].
2.

On March 26, 2012, at 2:00 p.m. (CT) [previously January 6, 2011, at 10:00 a.m.

(CT)], the Court will initiate and conduct a final pretrial conference call. Pursuant to Civil L. R.
16(c), each party must serve and file a final pretrial report in compliance with the Pretrial Report
Order previously issued.
3.

All requests for expert discovery must be served by a date sufficiently early so

that all expert discovery in this case can be completed no later than February 17, 2012
[previously: December 16, 2011]. Neither the pendency of motions nor settlement discussions
shall affect any of the dates set in this action, and neither shall justify delays in the taking of
expert discovery.

4.

To provide the plaintiff the opportunity to seek preliminary relief in the event that

the defendants’ Abbreviated New Animal Drug Application (“ANADA”) is finally approved, the
defendants must not sell or offer for sale their accused ANADA product unless and until 25 days
after they have provided the plaintiff with notice that the Food and Drug Administration has
issued a final approval of the defendants’ ANADA.
5.

The stay of FDA approval of defendants’ ANADA is EXTENDED through the

April 16, 2012 trial. See Dkt. 200.

Dated at Milwaukee, Wisconsin, this 9th day of December, 2011.
BY THE COURT:

__________________________
HON. RUDOLPH T. RANDA
U.S. District Judge

2